We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
PUT
Apple
AAPL
$4.89T
| $5.19M | 0.02% |
37,900
-187,000
| -83% | -$24.2M |
|
|
DCRCW
802
CALL
DELISTED
Decarbonization Plus Acquisition Corporation III Warrant
DCRCW
| $5.18M | 0.02% |
+499,997
| New | +$963K |
|
|
CANG
803
Cango Inc
CANG
$69.3M
| $5.18M | 0.02% |
92,708
+10,570
| +13% | +$645K |
|
804
PUT
Target
TGT
$62.1B
| $5.17M | 0.02% |
21,400
-13,400
| -39% | -$2.93M |
|
805
Zscaler
ZS
$23B
| $5.16M | 0.02% |
23,899
+20,783
| +667% | +$3.95M |
|
|
KL
806
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $5.16M | 0.02% |
133,887
+14,672
| +12% | +$588K |
|
807
Adobe
ADBE
$89.5B
| $5.16M | 0.02% |
8,805
-61,903
| -88% | -$31.9M |
|
808
Microchip Technology
MCHP
$42.8B
| $5.15M | 0.02% |
+68,818
| New | +$5.24M |
|
809
Tronox
TROX
$995M
| $5.15M | 0.02% |
229,940
-255,967
| -53% | -$5.62M |
|
810
Xos
XOS
$27.7M
| $5.15M | 0.02% |
17,255
| – | – |
|
811
Ethan Allen Interiors
ETD
$581M
| $5.13M | 0.02% |
185,824
-167,983
| -47% | -$4.85M |
|
|
ORC
812
Orchid Island Capital
ORC
$1.31B
| $5.11M | 0.02% |
196,978
-122,427
| -38% | -$3.4M |
|
|
FTPA
813
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
| $5.11M | 0.02% |
+523,456
| New | +$5.17M |
|
814
Best Buy
BBY
$18B
| $5.1M | 0.02% |
44,384
-55,910
| -56% | -$6.52M |
|
815
Oxford Industries
OXM
$577M
| $5.08M | 0.02% |
+51,389
| New | +$4.82M |
|
816
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.35B
| $5.08M | 0.02% |
+125,211
| New | +$4.99M |
|
|
BFLY.WS
817
CALL
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
| $5.07M | 0.02% |
350,000
+50,000
| +17% | +$228K |
|
|
ATSG
818
DELISTED
Air Transport Services Group
ATSG
| $5.06M | 0.02% |
+217,791
| New | +$5.64M |
|
819
New Fortress Energy
NFE
$101M
| $5.06M | 0.02% |
133,539
-67,515
| -34% | -$2.89M |
|
820
West Fraser Timber
WFG
$5.18B
| $5.05M | 0.02% |
70,309
-73,417
| -51% | -$5.64M |
|
|
YTPG
821
DELISTED
TPG Pace Beneficial II Corp.
YTPG
| $5.04M | 0.02% |
+500,000
| New | +$5.05M |
|
822
TMC The Metals Company
TMC
$1.59B
| $5.02M | 0.02% |
504,587
+29,599
| +6% | +$294K |
|
823
FirstEnergy
FE
$28.9B
| $5.02M | 0.02% |
134,913
+127,455
| +1,709% | +$4.74M |
|
824
AstraZeneca
AZN
$263B
| $5.01M | 0.02% |
41,831
-53,042
| -56% | -$5.82M |
|
|
EOCW.U
825
DELISTED
Elliott Opportunity II Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
EOCW.U
| $5M | 0.02% |
+500,000
| New | +$5.01M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.